SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-122207 from Alector, Inc. (ALEC) (CIK 0001653087) (ALEC)

Alector, Inc. (ALEC) (CIK 0001653087)
Date: April 27, 2023 · CIK: 0001653087 · Accession: 0001193125-23-122207

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-270126

Date
April 27, 2023
Author
By
Form
CORRESP
Company
Alector, Inc. (ALEC) (CIK 0001653087)

Letter

April 27, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention: Jason Drory

Re:

Alector, Inc.

Registration Statement on Form S-3

Filed February 28, 2023

File No. 333-270126

Acceleration Request

Requested Date:

May 1, 2023

Requested Time:

4:05 p.m. Eastern Time,

or as soon thereafter as practicable

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Alector, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-270126) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Michael Coke at (650) 565-3596.

Please direct any questions or comments regarding this acceleration request to Michael Coke.

Sincerely,
Alector, Inc.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 April 27, 2023

VIA EDGAR

 U.S. Securities and Exchange
Commission

 Division of Corporation Finance

 Office of Life
Sciences

 100 F Street, N.E.

 Washington, D.C. 20549-3720

 Attention: Jason Drory

Re:

Alector, Inc.

Registration Statement on Form S-3

Filed February 28, 2023

File No. 333-270126

Acceleration Request

Requested Date:

May 1, 2023

Requested Time:

4:05 p.m. Eastern Time,

or as soon thereafter as practicable

 Ladies and Gentlemen:

 Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Alector, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-270126) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its
counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

 Once the
Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Michael Coke at (650)
565-3596.

 Please direct any questions or comments regarding this acceleration request to Michael Coke.

Sincerely,

Alector, Inc.

By:

/s/ Arnon Rosenthal

Arnon Rosenthal, Ph.D.

Co-founder and Chief Executive Officer

cc:
 Michael E. Coke, Wilson Sonsini Goodrich & Rosati, Professional Corporation

 Alector

 131 Oyster Point Blvd, Suite
600

South San Francisco, CA 94080

alector.com